Project Grant HT94252410232
Award Date
9/1/24
Completion Date
8/31/28
Dollars Obligated
$3.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Scottsdale, AZ 85259, USA
Similar Awards
The Defense Health Agency has awarded a $968,400 Project Grant to Mayo Clinic to develop a personalized approach to treating drug-resistant ovarian cancer. The grant, which began on June 1, 2024, and will run through May 31, 2028, is funded under the Military Medical Research and Development program (CFDA 12.420). This program supports biomedical research to improve the health and care of military service members, veterans, and their families. Through this award, Mayo Clinic will leverage its...
The Mayo Clinic was awarded a $1.7 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will support research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research...
The Mayo Clinic received a $278,250 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from August 2021 through July 2025 to develop techniques for cytokine modulation of chimeric antigen receptor T cells to increase their safety and efficacy. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research solutions...
The Defense Health Agency awarded a $597,543.00 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, a nonprofit academic medical center. The grant, which runs from October 1, 2023 to September 14, 2026, is funded under the Military Medical Research and Development program (CFDA 12.420) to support research aimed at "elucidating mechanisms of CAR-T cell immunotherapy resistance and sensitivity to improve treatment of myeloma." As a nonprofit organization with...
The federal Project Grant award of $161,400.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support Mayo Clinic's research project titled "AN ATLAS OF THE TUMOR IMMUNE CIRCULOME." This award, with a performance period from June 1, 2024 to May 31, 2025, aims to advance medical knowledge and improve patient care through innovative biomedical research. The Military Medical Research and Development program funds a wide range of...
This Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) provides $2,455,718.00 to Mayo Clinic in Rochester, Minnesota to conduct NKG7-armed tumor-infiltrating lymphocyte therapy research for metastatic uveal melanoma. The award period runs from September 1, 2025 through August 31, 2029. This research project aims to advance medical solutions for the battlefield and transform healthcare for military service members...
The Defense Health Agency awarded a $408,467 Project Grant to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, for a research project titled "METABOLIC REPROGRAMMING OF CAR MACROPHAGES FOR OVARIAN CANCER IMMUNOTHERAPY." The award period runs from September 1, 2023, to August 31, 2025, under the Military Medical Research and Development (CFDA 12.420) federal grant program. The project aims to study the metabolic reprogramming of chimeric antigen receptor (CAR) macrophages to...
The Mayo Clinic will identify novel protein biomarkers and targets to overcome PARP inhibitor resistance under a $954,000 project grant from the Department of the Army Medical Command. The grant was awarded on June 15, 2021 with a completion date of June 14, 2025 under the Military Medical Research and Development program (CFDA 12.420). This program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for...
This $476,999 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the Mayo Clinic's research on targeting the AXL receptor tyrosine kinase with a humanized anti-AXL monoclonal antibody as a novel therapy for ovarian cancer. The 4-year project aims to develop and evaluate this antibody-based treatment for ovarian cancer. As a leading non-profit academic medical center, Mayo Clinic leverages its expertise in...
This $795,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Mayo Clinic's research to develop a humanized anti-AXL monoclonal antibody as a novel therapy for ovarian cancer. The 4-year project aims to target the AXL receptor tyrosine kinase as a potential new treatment approach. As an experienced biomedical research institution, Mayo Clinic will leverage its expertise in preclinical pharmacokinetic...